Most Read Articles
Stephen Padilla, 05 Jan 2018
The addition of an antihypertensive drug from a new class to a patient’s regimen results in huge decreases in systolic blood pressure (SBP) and major cardiovascular (CV) events among those at high risk for CV events but without diabetes, suggests a recent study. Its effects on SBP remain large and similar in magnitude across all levels of baseline drug use and all subgroups of patients.
Pearl Toh, 4 days ago
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Yesterday
The risk of stroke and subsequent mortality is significantly elevated in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), a recent study has shown.
Roshini Claire Anthony, 10 Jan 2018

Adding rifampicin to standard antibiotic therapy does not improve outcomes in individuals with Staphylococcus aureus (S. aureus) bacteraemia, the ARREST* trial shows. However, rifampicin may contribute towards a minor reduction in bacteraemia recurrence.

High- vs standard-dose vitamin D provides no added benefit on muscular strength, balance

17 Jul 2017

High-dose vitamin D supplementation for 12 months does not improve muscular strength, balance or quality of life in postmenopausal women with osteopenia or osteoporosis as compared with standard-dose supplementation, according to a study.

Researchers randomized 297 postmenopausal women with osteoporosis or osteopenia to 12-month treatment with vitamin D3 (20,000 IU) or matching placebos taken twice a week. All women also received daily elemental calcium (1,000 mg) plus vitamin D3 (800 IU).

Evaluations including muscle strength (handgrip and knee extensor strength), balance (tandem test) and quality of life (EQ-5D) were performed at baseline and after 12 months. In addition, the women were genotyped for single nucleotide polymorphisms (SNPs) in genes encoding vitamin D-related enzymes.

Among the 275 women who completed the study, mean serum 25(OH)D levels significantly increased in the high-dose group (from 64.7 to 164.1 nmol/L; p<0.01) and moderately increased in the standard-dose group (from 64.1 to 81.8 nmol/L; p<0.01). However, no significant between-group difference was observed in change in muscular strength, balance or quality of life over the intervention period.

Of note was the observed association of polymorphisms in rs3829251 (located in the 7-dehydrocholesterol reductase gene) with muscle strength and treatment effects.

Findings of the present study, designed to compare two doses of supplemental vitamin D and not to assess the effect of vitamin D itself, do not lend support for the use of high-dose vitamin D supplements in already vitamin D-replete women in terms of improving muscular strength, balance or quality of life, researchers said.

While not having shown any indication of harmful clinical effects, high-dose vitamin D supplementation might lead to a minor increase in serum and urinary calcium, they added. Furthermore, the safety assessment in the study was limited by the inability to specifically assess falls. Future studies should include vitamin-D deficient participants only, as well as assess fall as an outcome measure in all high-dose vitamin D trials.

Vitamin D has an important and well-known effect on calcium homeostasis and skeletal health. In light of the discovery of vitamin D receptors and the vitamin D activating enzyme 1-alfa-hydroxylase in extraskeletal tissues, recent data have demonstrated associations between higher serum 25(OH)D levels and lower risk of multiple pathological conditions. [Ann N Y Acad Sci 2016;1376:29-52; Am J Clin Nutr 2004;80:1689s-96s; J Clin Endocrinol Metab 2007;92:2058-65]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Stephen Padilla, 05 Jan 2018
The addition of an antihypertensive drug from a new class to a patient’s regimen results in huge decreases in systolic blood pressure (SBP) and major cardiovascular (CV) events among those at high risk for CV events but without diabetes, suggests a recent study. Its effects on SBP remain large and similar in magnitude across all levels of baseline drug use and all subgroups of patients.
Pearl Toh, 4 days ago
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Yesterday
The risk of stroke and subsequent mortality is significantly elevated in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), a recent study has shown.
Roshini Claire Anthony, 10 Jan 2018

Adding rifampicin to standard antibiotic therapy does not improve outcomes in individuals with Staphylococcus aureus (S. aureus) bacteraemia, the ARREST* trial shows. However, rifampicin may contribute towards a minor reduction in bacteraemia recurrence.